A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
- PMID: 7647779
- DOI: 10.1038/ng0595-111
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
Abstract
Hyperhomocysteinaemia has been identified as a risk factor for cerebrovascular, peripheral vascular and coronary heart disease. Elevated levels of plasma homocysteine can result from genetic or nutrient-related disturbances in the trans-sulphuration or re-methylation pathways for homocysteine metabolism. 5, 10-Methylenetetrahydrofolate reductase (MTHFR) catalyzes the reduction of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the predominant circulatory form of folate and carbon donor for the re-methylation of homocysteine to methionine. Reduced MTHFR activity with a thermolabile enzyme has been reported in patients with coronary and peripheral artery disease. We have identified a common mutation in MTHFR which alters a highly-conserved amino acid; the substitution occurs at a frequency of approximately 38% of unselected chromosomes. The mutation in the heterozygous or homozygous state correlates with reduced enzyme activity and increased thermolability in lymphocyte extracts; in vitro expression of a mutagenized cDNA containing the mutation confirms its effect on thermolability of MTHFR. Finally, individuals homozygous for the mutation have significantly elevated plasma homocysteine levels. This mutation in MTHFR may represent an important genetic risk factor in vascular disease.
Similar articles
-
The thermolabile variant 677C-->T can further reduce activity when expressed in cis with severe mutations for human methylenetetrahydrofolate reductase.Hum Mutat. 2000;16(2):132-8. doi: 10.1002/1098-1004(200008)16:2<132::AID-HUMU5>3.0.CO;2-T. Hum Mutat. 2000. PMID: 10923034
-
Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.Thromb Haemost. 1998 Feb;79(2):254-8. Thromb Haemost. 1998. PMID: 9493571
-
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.Cancer Res. 1997 Mar 15;57(6):1098-102. Cancer Res. 1997. PMID: 9067278 Clinical Trial.
-
Molecular biology of 5,10-methylenetetrahydrofolate reductase.J Nephrol. 2000 Jan-Feb;13(1):20-33. J Nephrol. 2000. PMID: 10720211 Review.
-
[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].Pathol Biol (Paris). 2003 Mar;51(2):101-10. doi: 10.1016/s0369-8114(03)00104-4. Pathol Biol (Paris). 2003. PMID: 12801808 Review. French.
Cited by
-
MTHFR C677T, hyperhomocysteinemia, and their interactions with traditional risk factors in early neurological deterioration in Chinese patients with ischemic stroke.Heliyon. 2024 May 9;10(10):e31003. doi: 10.1016/j.heliyon.2024.e31003. eCollection 2024 May 30. Heliyon. 2024. PMID: 38784530 Free PMC article.
-
Association between Psoriasis and MTHFR polymorphisms: a systematic review and meta-analysis.Arch Dermatol Res. 2024 May 21;316(5):184. doi: 10.1007/s00403-024-02905-5. Arch Dermatol Res. 2024. PMID: 38771513 Review.
-
The Dawn and Advancement of the Knowledge of the Genetics of Migraine.J Clin Med. 2024 May 4;13(9):2701. doi: 10.3390/jcm13092701. J Clin Med. 2024. PMID: 38731230 Free PMC article. Review.
-
Interactions between folate metabolism-related nutrients and polymorphisms on colorectal cancer risk: a case-control study in the Basque country.Eur J Nutr. 2024 Apr 23. doi: 10.1007/s00394-024-03371-5. Online ahead of print. Eur J Nutr. 2024. PMID: 38652304
-
Dynamic inter-domain transformations mediate the allosteric regulation of human 5, 10-methylenetetrahydrofolate reductase.Nat Commun. 2024 Apr 15;15(1):3248. doi: 10.1038/s41467-024-47174-y. Nat Commun. 2024. PMID: 38622112 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials